{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T17:13:37Z","timestamp":1761498817572,"version":"build-2065373602"},"reference-count":59,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice &amp; Research Clinical Haematology"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.beha.2021.101327","type":"journal-article","created":{"date-parts":[[2021,10,25]],"date-time":"2021-10-25T14:03:15Z","timestamp":1635170595000},"page":"101327","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["How predictive is the finding of clonal hematopoiesis for the development of myelodysplastic syndromes (MDS) or acute myeloid leukemia (AML)?"],"prefix":"10.1016","volume":"34","author":[{"given":"David P.","family":"Steensma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.beha.2021.101327_bib1","doi-asserted-by":"crossref","DOI":"10.1126\/science.aan4673","article-title":"Clonal hematopoiesis in human aging and disease","volume":"366","author":"Jaiswal","year":"2019","journal-title":"Science"},{"key":"10.1016\/j.beha.2021.101327_bib2","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1182\/blood.2020008407","article-title":"To portray clonal evolution in blood cancer, count your stem cells","volume":"137","author":"Lyne","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.beha.2021.101327_bib3","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1126\/science.aay9333","article-title":"The evolutionary dynamics and fitness landscape of clonal hematopoiesis","volume":"367","author":"Watson","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.beha.2021.101327_bib4","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/s41568-021-00335-3","article-title":"Clonal expansion in non-cancer tissues","volume":"21","author":"Kakiuchi","year":"2021","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.beha.2021.101327_bib5","doi-asserted-by":"crossref","first-page":"12484","DOI":"10.1038\/ncomms12484","article-title":"Clonal haematopoiesis harbouring AML-associated mutations is ubiquitous in healthy adults","volume":"7","author":"Young","year":"2016","journal-title":"Nat Commun"},{"key":"10.1016\/j.beha.2021.101327_bib6","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1038\/nature19768","article-title":"Tissue-specific mutation accumulation in human adult stem cells during life","volume":"538","author":"Blokzijl","year":"2016","journal-title":"Nature"},{"issue":"7859","key":"10.1016\/j.beha.2021.101327_bib7","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/s41586-021-03477-4","article-title":"Somatic mutation landscapes at single-molecule resolution","volume":"593","author":"Abascal","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.beha.2021.101327_bib8","doi-asserted-by":"crossref","first-page":"3550","DOI":"10.1182\/bloodadvances.2020001582","article-title":"High prevalence of clonal hematopoiesis in the blood and bone marrow of healthy volunteers","volume":"4","author":"Guermouche","year":"2020","journal-title":"Blood Adv"},{"key":"10.1016\/j.beha.2021.101327_bib9","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1182\/blood-2017-04-777029","article-title":"DNMT3A and TET2 dominate clonal hematopoiesis and demonstrate benign phenotypes and different genetic predispositions","volume":"130","author":"Buscarlet","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.beha.2021.101327_bib10","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.exphem.2019.12.001","article-title":"Clonal hematopoiesis as a model for premalignant changes during aging","volume":"83","author":"Steensma","year":"2020","journal-title":"Exp Hematol"},{"key":"10.1016\/j.beha.2021.101327_bib11","doi-asserted-by":"crossref","first-page":"2488","DOI":"10.1056\/NEJMoa1408617","article-title":"Age-related clonal hematopoiesis associated with adverse outcomes","volume":"371","author":"Jaiswal","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.beha.2021.101327_bib12","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1056\/NEJMoa1409405","article-title":"Clonal hematopoiesis and cancer risk in blood derived DNA sequence","volume":"371","author":"Genovese","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.beha.2021.101327_bib13","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1038\/nm.3733","article-title":"Age-related mutations associated with clonal hematopoietic expansion and malignancies","volume":"20","author":"Xie","year":"2014","journal-title":"Nat Med"},{"key":"10.1016\/j.beha.2021.101327_bib14","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1056\/NEJMoa1701719","article-title":"Clonal hematopoiesis and risk of atherosclerotic cardiovascular disease","volume":"377","author":"Jaiswal","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.beha.2021.101327_bib15","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.jacc.2019.06.007","article-title":"Clonal hematopoiesis: crossroads of aging, cardiovascular disease, and cancer: JACC review topic of the week","volume":"74","author":"Libby","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.beha.2021.101327_bib16","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1182\/blood-2017-02-769869","article-title":"Clonal hematopoiesis, with and without candidate driver mutations, is common in the elderly","volume":"130","author":"Zink","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.beha.2021.101327_bib17","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1182\/blood-2015-03-631747","article-title":"Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes","volume":"126","author":"Steensma","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.beha.2021.101327_bib18","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.jmoldx.2019.12.003","article-title":"Apparently heterozygous TP53 pathogenic variants may Be blood limited in patients undergoing hereditary cancer panel testing","volume":"22","author":"Mester","year":"2020","journal-title":"J Mol Diagn"},{"key":"10.1016\/j.beha.2021.101327_bib19","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1038\/ng.2271","article-title":"Detectable clonal mosaicism from birth to old age and its relationship to cancer","volume":"44","author":"Laurie","year":"2012","journal-title":"Nat Genet"},{"key":"10.1016\/j.beha.2021.101327_bib20","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1038\/ng.2270","article-title":"Detectable clonal mosaicism and its relationship to aging and cancer","volume":"44","author":"Jacobs","year":"2012","journal-title":"Nat Genet"},{"key":"10.1016\/j.beha.2021.101327_bib21","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.stem.2021.02.001","article-title":"Reconstructing the lineage histories and differentiation trajectories of individual cancer cells in myeloproliferative neoplasms","volume":"28","author":"Van Egeren","year":"2021","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.beha.2021.101327_bib22","first-page":"1623","article-title":"What to tell your patient with clonal hematopoiesis and why: insights from 2 specialized clinics","volume":"136","author":"Steensma","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.beha.2021.101327_bib23","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.exphem.2020.01.013","article-title":"Clonal hematopoiesis in hematological disorders: three different scenarios","volume":"83","author":"Swierczek","year":"2020","journal-title":"Exp Hematol"},{"key":"10.1016\/j.beha.2021.101327_bib24","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1056\/NEJMc1806413","article-title":"High-risk clonal hematopoiesis as the origin of AITL and NPM1-mutated AML","volume":"379","author":"Tiacci","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.beha.2021.101327_bib25","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.stem.2018.10.004","article-title":"PPM1D mutations drive clonal hematopoiesis in response to cytotoxic chemotherapy","volume":"23","author":"Hsu","year":"2018","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.beha.2021.101327_bib26","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1182\/blood.2019004770","article-title":"Clonal hematopoiesis and measurable residual disease assessment in acute myeloid leukemia","volume":"135","author":"Hasserjian","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.beha.2021.101327_bib27","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1056\/NEJMoa1106968","article-title":"Clonal architecture of secondary acute myeloid leukemia","volume":"366","author":"Walter","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.beha.2021.101327_bib28","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1056\/NEJMoa1716863","article-title":"Molecular minimal residual disease in acute myeloid leukemia","volume":"378","author":"Jongen-Lavrencic","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.beha.2021.101327_bib29","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1038\/s41586-018-0321-x","article-title":"Insights into clonal haematopoiesis from 8,342 mosaic chromosomal alterations","volume":"559","author":"Loh","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.beha.2021.101327_bib30","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1038\/s41586-019-1765-3","article-title":"Genetic predisposition to mosaic Y chromosome loss in blood","volume":"575","author":"Thompson","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.beha.2021.101327_bib31","doi-asserted-by":"crossref","first-page":"555","DOI":"10.3324\/haematol.2019.240689","article-title":"Genomic alterations in patients with somatic loss of the Y chromosome as the sole cytogenetic finding in bone marrow cells","volume":"106","author":"Ouseph","year":"2021","journal-title":"Haematologica"},{"key":"10.1016\/j.beha.2021.101327_bib32","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1182\/blood-2016-03-643544","article-title":"The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia","volume":"127","author":"Arber","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.beha.2021.101327_bib33","doi-asserted-by":"crossref","first-page":"3371","DOI":"10.1182\/blood-2017-01-763425","article-title":"Clinical significance of somatic mutation in unexplained blood cytopenia","volume":"129","author":"Malcovati","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.beha.2021.101327_bib34","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1038\/s41586-018-0317-6","article-title":"Prediction of acute myeloid leukaemia risk in healthy individuals","volume":"559","author":"Abelson","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.beha.2021.101327_bib35","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1038\/s41591-018-0081-z","article-title":"Somatic mutations precede acute myeloid leukemia years before diagnosis","volume":"24","author":"Desai","year":"2018","journal-title":"Nat Med"},{"key":"10.1016\/j.beha.2021.101327_bib36","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.1182\/bloodadvances.2020003976","article-title":"Clinical, molecular, and prognostic comparisons between CCUS and lower-risk MDS: a study of 187 molecularly annotated patients","volume":"5","author":"Li","year":"2021","journal-title":"Blood Adv"},{"key":"10.1016\/j.beha.2021.101327_bib37","first-page":"1161","article-title":"Mutational spectrum and dynamics of clonal hematopoiesis in anemia of older individuals","volume":"135","author":"van Zeventer","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.beha.2021.101327_bib38","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1182\/bloodadvances.2020004062","article-title":"Prevalence, predictors, and outcomes of clonal hematopoiesis in individuals aged >\/=80 years","volume":"5","author":"van Zeventer","year":"2021","journal-title":"Blood Adv"},{"key":"10.1016\/j.beha.2021.101327_bib39","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.hoc.2018.03.002","article-title":"Somatic mutations in aplastic anemia","volume":"32","author":"Mufti","year":"2018","journal-title":"Hematol Oncol Clin N Am"},{"key":"10.1016\/j.beha.2021.101327_bib40","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1056\/NEJMoa1414799","article-title":"Somatic mutations and clonal hematopoiesis in aplastic anemia","volume":"373","author":"Yoshizato","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.beha.2021.101327_bib41","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1002\/ajh.24552","article-title":"Clonal hematopoiesis in patients with dyskeratosis congenita","volume":"91","author":"Perdigones","year":"2016","journal-title":"Am J Hematol"},{"key":"10.1016\/j.beha.2021.101327_bib42","doi-asserted-by":"crossref","first-page":"2484","DOI":"10.1182\/blood-2015-04-641100","article-title":"Genomic analysis of germ line and somatic variants in familial myelodysplasia\/acute myeloid leukemia","volume":"126","author":"Churpek","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.beha.2021.101327_bib43","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1038\/s41467-021-21588-4","article-title":"Distinct genetic pathways define pre-malignant versus compensatory clonal hematopoiesis in Shwachman-Diamond syndrome","volume":"12","author":"Kennedy","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.beha.2021.101327_bib44","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1182\/bloodadvances.2020003858","article-title":"Precocious clonal hematopoiesis in Down syndrome is accompanied by immune dysregulation","volume":"5","author":"Liggett","year":"2021","journal-title":"Blood Adv"},{"key":"10.1016\/j.beha.2021.101327_bib45","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.ccell.2015.03.017","article-title":"Inherited and somatic defects in DDX41 in myeloid neoplasms","volume":"27","author":"Polprasert","year":"2015","journal-title":"Cancer Cell"},{"key":"10.1016\/j.beha.2021.101327_bib46","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/s41590-020-0663-z","article-title":"Adaptive response to inflammation contributes to sustained myelopoiesis and confers a competitive advantage in myelodysplastic syndrome HSCs","volume":"21","author":"Muto","year":"2020","journal-title":"Nat Immunol"},{"key":"10.1016\/j.beha.2021.101327_bib47","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.exphem.2020.01.011","article-title":"Clonal hematopoiesis and inflammation: partners in leukemogenesis and comorbidity","volume":"83","author":"Cook","year":"2020","journal-title":"Exp Hematol"},{"key":"10.1016\/j.beha.2021.101327_bib48","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1200\/JCO.2016.71.6712","article-title":"Clonal hematopoiesis associated with adverse outcomes after autologous stem-cell transplantation for lymphoma","volume":"35","author":"Gibson","year":"2017","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.beha.2021.101327_bib49","doi-asserted-by":"crossref","first-page":"2996","DOI":"10.1038\/s41467-020-16805-5","article-title":"Clonal hematopoiesis is associated with adverse outcomes in multiple myeloma patients undergoing transplant","volume":"11","author":"Mouhieddine","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.beha.2021.101327_bib50","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1200\/JCO.2018.79.2184","article-title":"Role of donor clonal hematopoiesis in allogeneic hematopoietic stem-cell transplantation","volume":"37","author":"Frick","year":"2019","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.beha.2021.101327_bib51","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1182\/bloodadvances.2019000395","article-title":"Stem cell donors should not be screened for clonal hematopoiesis","volume":"4","author":"Gibson","year":"2020","journal-title":"Blood Adv"},{"key":"10.1016\/j.beha.2021.101327_bib52","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aax6249","article-title":"Engraftment of rare, pathogenic donor hematopoietic mutations in unrelated hematopoietic stem cell transplantation","volume":"12","author":"Wong","year":"2020","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.beha.2021.101327_bib53","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.exphem.2020.09.197","article-title":"Hand in hand: intrinsic and extrinsic drivers of aging and clonal hematopoiesis","volume":"91","author":"SanMiguel","year":"2020","journal-title":"Exp Hematol"},{"key":"10.1016\/j.beha.2021.101327_bib54","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/nrclinonc.2017.197","article-title":"The bone-marrow niche in MDS and MGUS: implications for AML and MM","volume":"15","author":"Ghobrial","year":"2018","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.beha.2021.101327_bib55","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1200\/JCO.19.01823","article-title":"Integrating the \"immunome\" in the stratification of myelodysplastic syndromes and future clinical trial design","volume":"38","author":"Winter","year":"2020","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.beha.2021.101327_bib56","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1038\/s41588-020-00710-0","article-title":"Cancer therapy shapes the fitness landscape of clonal hematopoiesis","volume":"52","author":"Bolton","year":"2020","journal-title":"Nat Genet"},{"key":"10.1016\/j.beha.2021.101327_bib57","doi-asserted-by":"crossref","DOI":"10.1038\/s41375-021-01150-3","article-title":"Therapy-related leukaemias with balanced translocations can arise from pre-existing clonal haematopoiesis","author":"Dillon","year":"2021","journal-title":"Leukemia"},{"key":"10.1016\/j.beha.2021.101327_bib58","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.stem.2017.07.010","article-title":"Therapy-related clonal hematopoiesis in patients with non-hematologic cancers is common and associated with adverse clinical outcomes","volume":"21","author":"Coombs","year":"2017","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.beha.2021.101327_bib59","first-page":"1599","article-title":"Clonal hematopoiesis and risk for hematologic malignancy","volume":"136","author":"Warren","year":"2020","journal-title":"Blood"}],"container-title":["Best Practice &amp; Research Clinical Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152169262100092X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152169262100092X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T17:06:28Z","timestamp":1761498388000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S152169262100092X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":59,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["S152169262100092X"],"URL":"https:\/\/doi.org\/10.1016\/j.beha.2021.101327","relation":{},"ISSN":["1521-6926"],"issn-type":[{"type":"print","value":"1521-6926"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"How predictive is the finding of clonal hematopoiesis for the development of myelodysplastic syndromes (MDS) or acute myeloid leukemia (AML)?","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Haematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.beha.2021.101327","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"101327"}}